Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Brentuximab vedotin.
[hodgkin lymphoma, classical]
Brentuximab
vedotin
is
an
anti-
CD
30
antibody-drug
conjugate
with
proven
efficacy
in
patients
with
CD
30
(
+
)
malignancies
,
including
classical
Hodgkin
lymphoma
and
anaplastic
large
cell
lymphoma
.
Promising
activity
has
also
been
seen
in
other
lymphomas
that
express
CD
30
.
Because
of
its
acceptable
toxicity
profile
and
significant
clinical
efficacy
,
single
-
agent
brentuximab
vedotin
is
an
approved
treatment
for
relapsed
patients
with
these
diseases
.
Brentuximab
vedotin
has
safely
been
combined
with
chemotherapy
and
is
now
being
compared
with
standard
treatments
in
randomized
trials
.
Diseases
Validation
Diseases presenting
"single-agent brentuximab vedotin is an approved treatment for relapsed patients with these diseases"
symptom
hodgkin lymphoma, classical
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom